The Food and Drug Administration approved Novo Nordisk’s Ozempic as the first GLP-1 treatment option for people with type 2 ...

A new report highlights the changing perceptions of travel media and marketing, exploring how luxury and lifestyle hotel brands can succeed in attracting a dynamically diverse cohort of luxury ...